EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in Axons

Christina Antoniou, Andrea Loreto, Jonathan Gilley, Elisa Merlini, Giuseppe Orsomando, Michael P Coleman

Molecular Neurobiology · 2025

DOI: 10.1007/s12035-024-04480-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Christina Antoniou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY,…. Hauptthemen laut MEDLINE: Nicotinamide-Nucleotide Adenylyltransferase, Axons, Armadillo Domain Proteins, Cytoskeletal Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) is an endogenous axon survival factor that maintains axon health by blocking activation of the downstream pro-degenerative protein SARM1 (sterile alpha and TIR motif containing protein 1). While complete absence of NMNAT2 in mice results in extensive axon truncation and perinatal lethality, the removal of SARM1 completely rescues these phenotypes. Reduced levels of NMNAT2 can be compatible with life; however, they compromise axon development and survival. Mice born expressing sub-heterozygous levels of NMNAT2 remain overtly normal into old age but develop axonal defects in vivo and in vitro as well as behavioural phenotypes. Therefore, it is important to examine the effects of constitutively low NMNAT2 expression on SARM1 activation and disease susceptibility. Here we demonstrate that chronically low NMNAT2 levels reduce prenatal viability in mice in a SARM1-dependent manner and lead to sub-lethal SARM1 activation in morphologically intact axons of superior cervical ganglion (SCG) primary cultures. This is characterised by a depletion in NAD(P) and compromised neurite outgrowth. We also show that chronically low NMNAT2 expression reverses the NAD-enhancing effect of nicotinamide riboside (NR) in axons in a SARM1-dependent manner. These data indicate that low NMNAT2 levels can trigger sub-lethal SARM1 activation which is detectable at the molecular level and could predispose to human axonal disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nicotinamide-Nucleotide AdenylyltransferaseAxonsArmadillo Domain ProteinsCytoskeletal ProteinsNiacinamideAnimalsMiceMice, Inbred C57BLNADCells, CulturedPyridinium Compounds

Stichwörter der Autor:innen

NADNMNAT2Programmed axon deathSARM1

Substanzen

Nicotinamide-Nucleotide AdenylyltransferaseArmadillo Domain ProteinsCytoskeletal ProteinsNmnat2 protein, mouseSARM1 protein, mouseNiacinamidenicotinamide-beta-ribosideNADPyridinium Compounds

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK.
  • School of Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
  • Department of Clinical Sciences (DISCO), Section of Biochemistry, Polytechnic University of Marche, Via Ranieri 67, 60131, Ancona, Italy.
  • Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0PY, UK. mc469@cam.ac.uk.

Förderung

  • Wellcome Trust

Zitieren

APA

Antoniou, C., Loreto, A., Gilley, J., Merlini, E., Orsomando, G., & Coleman, M. P. (2025). Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in Axons. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04480-2

Vancouver

Antoniou C, Loreto A, Gilley J, Merlini E, Orsomando G, Coleman MP. Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in Axons. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04480-2

BibTeX
@article{Antoniou2025,
  author = {Antoniou, Christina and Loreto, Andrea and Gilley, Jonathan and Merlini, Elisa and Orsomando, Giuseppe and Coleman, Michael P},
  title = {Chronically Low NMNAT2 Expression Causes Sub-lethal SARM1 Activation and Altered Response to Nicotinamide Riboside in Axons},
  journal = {Molecular Neurobiology},
  year = {2025},
  doi = {10.1007/s12035-024-04480-2}
}
Kostenlos starten →